Promising Cannabis Stocks To Keep An Eye On – August 12th

Tilray Brands, Canopy Growth, and Indivior are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies engaged in the cultivation, processing, distribution or retail sale of cannabis and hemp-derived products. Investors in these stocks gain exposure to the legal cannabis industry, which is characterized by rapid growth, evolving regulations and higher-than-average market volatility. Prices of cannabis stocks often fluctuate based on changes in legislation, consumer demand and competitive dynamics within the sector. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Tilray Brands (TLRY)

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Shares of TLRY stock traded up $0.09 on Tuesday, reaching $1.01. 210,216,418 shares of the company’s stock traded hands, compared to its average volume of 38,017,277. The business’s 50 day moving average price is $0.53 and its two-hundred day moving average price is $0.61. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.49 and a current ratio of 2.46. Tilray Brands has a 12-month low of $0.35 and a 12-month high of $1.98. The company has a market capitalization of $1.12 billion, a P/E ratio of -0.44 and a beta of 1.85.

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

NASDAQ CGC traded up $0.02 on Tuesday, reaching $1.60. The stock had a trading volume of 44,075,892 shares, compared to its average volume of 9,208,656. The business has a 50 day moving average price of $1.24 and a 200 day moving average price of $1.35. The company has a current ratio of 3.12, a quick ratio of 2.10 and a debt-to-equity ratio of 0.62. Canopy Growth has a 1 year low of $0.77 and a 1 year high of $7.21. The company has a market capitalization of $327.21 million, a price-to-earnings ratio of -0.53 and a beta of 0.67.

Indivior (INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Shares of NASDAQ:INDV traded up $0.58 on Tuesday, reaching $22.87. The company had a trading volume of 1,447,120 shares, compared to its average volume of 1,791,229. Indivior has a twelve month low of $7.33 and a twelve month high of $22.90. The stock has a 50-day moving average price of $16.02 and a 200 day moving average price of $12.32.